 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || AUR-107 / Dr. Reddy's
Enrollment open: A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) (clinicaltrials.gov) - Jan 31, 2024
P1, N=50, Recruiting, Sponsor: Aurigene Discovery Technologies Limited
Not yet recruiting --> Recruiting
- || AUR-107 / Dr. Reddy's
New P1 trial, Metastases: A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1) (clinicaltrials.gov) - May 18, 2023
P1, N=50, Not yet recruiting, Sponsor: Aurigene Discovery Technologies Limited